99 related articles for article (PubMed ID: 18604245)
1. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
Hirose K; Abramovich C; Argiropoulos B; Humphries RK
Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
[TBL] [Abstract][Full Text] [Related]
2. The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
Lavau CP; Aumann WK; Sze SK; Gupta V; Ripple K; Port SA; Kehlenbach RH; Wechsler DS
PLoS One; 2020; 15(4):e0232036. PubMed ID: 32343715
[TBL] [Abstract][Full Text] [Related]
3. ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias.
Golovine K; Abalakov G; Lian Z; Chatla S; Karami A; Chitrala KN; Madzo J; Nieborowska-Skorska M; Huang J; Skorski T
Blood Cancer J; 2023 Mar; 13(1):42. PubMed ID: 36959186
[TBL] [Abstract][Full Text] [Related]
4. TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability.
Wang N; Kim HG; Cotta CV; Wan M; Tang Y; Klug CA; Cao X
EMBO J; 2006 Apr; 25(7):1469-80. PubMed ID: 16525506
[TBL] [Abstract][Full Text] [Related]
5. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.
Zhang Y; Guo Y; Gough SM; Zhang J; Vann KR; Li K; Cai L; Shi X; Aplan PD; Wang GG; Kutateladze TG
Nat Commun; 2020 Jul; 11(1):3339. PubMed ID: 32620764
[TBL] [Abstract][Full Text] [Related]
7. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.
Qiu JJ; Zeisig BB; Li S; Liu W; Chu H; Song Y; Giordano A; Schwaller J; Gronemeyer H; Dong S; So CW
Leukemia; 2015 May; 29(5):1153-62. PubMed ID: 25510432
[TBL] [Abstract][Full Text] [Related]
8. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
[TBL] [Abstract][Full Text] [Related]
9. Mutant
Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
[TBL] [Abstract][Full Text] [Related]
10. Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.
Mendes A; Jühlen R; Bousbata S; Fahrenkrog B
Cells; 2020 Jul; 9(7):. PubMed ID: 32664447
[TBL] [Abstract][Full Text] [Related]
11. Covalent inhibition of NSD1 histone methyltransferase.
Huang H; Howard CA; Zari S; Cho HJ; Shukla S; Li H; Ndoj J; González-Alonso P; Nikolaidis C; Abbott J; Rogawski DS; Potopnyk MA; Kempinska K; Miao H; Purohit T; Henderson A; Mapp A; Sulis ML; Ferrando A; Grembecka J; Cierpicki T
Nat Chem Biol; 2020 Dec; 16(12):1403-1410. PubMed ID: 32868895
[TBL] [Abstract][Full Text] [Related]
12. Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.
Kuo YH; Zaidi SK; Gornostaeva S; Komori T; Stein GS; Castilla LH
Blood; 2009 Apr; 113(14):3323-32. PubMed ID: 19179305
[TBL] [Abstract][Full Text] [Related]
13. The pediatric leukemia oncoprotein NUP98-KDM5A induces genomic instability that may facilitate malignant transformation.
Domingo-Reinés J; Montes R; Garcia-Moreno A; Gallardo A; Sanchez-Manas JM; Ellson I; Lamolda M; Calabro C; López-Escamez JA; Catalina P; Carmona-Sáez P; Real PJ; Landeira D; Ramos-Mejia V
Cell Death Dis; 2023 Jun; 14(6):357. PubMed ID: 37301844
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.
Michmerhuizen NL; Klco JM; Mullighan CG
Blood; 2020 Nov; 136(20):2275-2289. PubMed ID: 32766874
[TBL] [Abstract][Full Text] [Related]
15. Critical role of the platelet-derived growth factor receptor (PDGFR) beta transmembrane domain in the TEL-PDGFRbeta cytosolic oncoprotein.
Toffalini F; Hellberg C; Demoulin JB
J Biol Chem; 2010 Apr; 285(16):12268-78. PubMed ID: 20164181
[TBL] [Abstract][Full Text] [Related]
16. Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients.
Jahn E; Saadati M; Fenaux P; Gobbi M; Roboz GJ; Bullinger L; Lutsik P; Riedel A; Plass C; Jahn N; Walter C; Holzmann K; Hao Y; Naim S; Schreck N; Krzykalla J; Benner A; Keer HN; Azab M; Döhner K; Döhner H
Leukemia; 2023 Nov; 37(11):2336-2337. PubMed ID: 37789148
[No Abstract] [Full Text] [Related]
17. Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.
Terlecki-Zaniewicz S; Humer T; Eder T; Schmoellerl J; Heyes E; Manhart G; Kuchynka N; Parapatics K; Liberante FG; Müller AC; Tomazou EM; Grebien F
Nat Struct Mol Biol; 2021 Feb; 28(2):190-201. PubMed ID: 33479542
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel NUP98-RARA fusion transcript as the 14th variant of acute promyelocytic leukemia.
Zhu HH; Yang MC; Wang F; Lou YJ; Jin J; Li K; Zhang SZ
Am J Hematol; 2020 Jul; 95(7):E184-E186. PubMed ID: 32242976
[No Abstract] [Full Text] [Related]
19. NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis.
Xu H; Valerio DG; Eisold ME; Sinha A; Koche RP; Hu W; Chen CW; Chu SH; Brien GL; Park CY; Hsieh JJ; Ernst P; Armstrong SA
Cancer Cell; 2016 Dec; 30(6):863-878. PubMed ID: 27889185
[TBL] [Abstract][Full Text] [Related]
20. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
